September 9, 2026 – Labcorp announced the acquisition of MLM Medical Labs (MLM), a leading global central and specialty laboratory provider with operations across the United States, Germany and South Africa. Financial terms of the transaction were not disclosed.
The acquisition enhances Labcorp’s position as a leading independent central laboratory services provider by expanding its presence in key clinical research regions and strengthening its biomarker and specialty testing capabilities. The transaction expands Labcorp’s laboratory footprint and establishes Labcorp as the only central laboratory provider with a wholly owned laboratory network across four continents: North America, Europe, Asia and Africa. The combination brings together Labcorp’s global scale, breadth of scientific capabilities and operational infrastructure with MLM’s established laboratory network and science-led service model.
This integrated global infrastructure enhances Labcorp’s ability to support complex multinational clinical trials with consistent scientific, operational and regulatory oversight from a single trusted partner. The acquisition also expands Labcorp’s laboratory footprint in critical clinical research markets, including Africa, where MLM operates the continent’s first fully CAP-accredited central laboratory.